Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
76 /100
COMPONENT-LIMITED
Score updated Aug 18, 2026

YDES — YD Bio Ltd Dilution Risk Tracker

Track YDES dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track YDES — Get alerts when the score changes →

As of August 18, 2026, YD Bio Ltd (YDES) has a DilutionWatch DilutionScore of 76/100, rated CRITICAL dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. YD Bio Ltd has a market capitalization of $228.08M, 70.79M shares outstanding, 9 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊Float Risk
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 12%
💰 Capital Raise model 15%
• Under 12 months cash (11mo)
📉 Score Deterioration model 15%
• Score already CRITICAL (76/100) — events likely imminent
🔔 Track YDES — Get forecast alerts →

Market Data

Market Cap$228.08M
Shares Outstanding70.79M
FloatN/A
Cash$6.01M
Debt$22.3K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.2% shares (2026Q1 vs prior)
9 institutional holders · 170.1K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 60.2K shares
#2 Cerity Partners LLC 32.4K shares
#3 Cypress Capital Management LLC (WY) 30.7K shares
+ 6 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest16.3K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual YDES Dilution Snapshot

YD Bio Ltd (YDES) has a DilutionScore of 76/100, rated Critical dilution risk. Score date: August 18, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track YDES Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking YDES — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for YDES
YDES FDA Catalyst Timeline & Biotech Grade — BiotechSigns📄 YDES Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.